Gary L Disbrow

Gary L Disbrow

UNVERIFIED PROFILE

Are you Gary L Disbrow?   Register this Author

Register author
Gary L Disbrow

Gary L Disbrow

Publications by authors named "Gary L Disbrow"

Are you Gary L Disbrow?   Register this Author

17Publications

98Reads

46Profile Views

Progress towards a vaccine against Ebola to meet emergency medical countermeasure needs.

Vaccine 2019 Nov 2;37(48):7178-7182. Epub 2017 Dec 2.

Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2017.10.111DOI Listing
November 2019

Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks.

PLoS Negl Trop Dis 2018 04 5;12(4):e0006275. Epub 2018 Apr 5.

Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pntd.0006275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886391PMC
April 2018

Project BioShield and the Biomedical Advanced Research Development Authority: A ten year progress report on meeting U.S. preparedness objectives for threat agents.

Clin Infect Dis 2017 05 4;64(10):1430-1434. Epub 2017 Feb 4.

Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cix097DOI Listing
May 2017

The U.S. government's medical countermeasure portfolio management for nuclear and radiological emergencies: synergy from interagency cooperation.

Health Phys 2011 Sep;101(3):238-47

Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, Office of the Secretary, Department of Health and Human Services, 330 Independence Avenue SW, Room 644G, Washington, DC 20201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HP.0b013e3182135fbaDOI Listing
September 2011

Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant.

Breast Cancer Res Treat 2009 Jul 20;116(2):281-94. Epub 2008 Jul 20.

Department of Pathology, Georgetown University Medical School, NW, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-008-0127-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576819PMC
July 2009

Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.

J Virol 2007 Nov 5;81(22):12689-95. Epub 2007 Sep 5.

Department of Pathology, Georgetown University Medical Center, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00669-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2168992PMC
November 2007

Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo.

Cancer Res 2005 Dec;65(23):10854-61

Department of Pathology, Georgetown University Medical Center, Washington, District of Columbia 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1216DOI Listing
December 2005

Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene.

Cancer Res 2005 Aug;65(15):6534-42

McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-0083DOI Listing
August 2005

Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH.

J Virol 2005 May;79(9):5839-46

Department of Pathology, Georgetown University Medical School, Basic Science Building, Room 113, 3900 Reservoir Rd., NW, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://jvi.asm.org/cgi/doi/10.1128/JVI.79.9.5839-5846.2005
Publisher Site
http://dx.doi.org/10.1128/JVI.79.9.5839-5846.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1082759PMC
May 2005

The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein.

J Biol Chem 2005 Mar 17;280(11):10807-16. Epub 2005 Jan 17.

Department of Pathology and Oncology, Georgetown University Medical School, 3900 Reservoir Rd. NW, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M410343200DOI Listing
March 2005

Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16?

Virology 2005 Feb;332(1):102-13

Department of Pathology, Georgetown University Medical School, Preclinical Sciences Building, Room GR10C, 3900 Reservoir Road, NW, Box #571432, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.virol.2004.11.011DOI Listing
February 2005

Codon optimization of the HPV-16 E5 gene enhances protein expression.

Virology 2003 Jun;311(1):105-14

Department of Pathology, Georgetown University Medical School, Georgetown University Medical Center, Preclinical Science Building, Room GR10C, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0042-6822(03)00129-6DOI Listing
June 2003